SCHEMBL23704684

SCHEMBL23704684

C[C@H](CCC(=O)OCOC(=O)CCP(=O)(O)CC(CCC(=O)O)C(=O)O)[C@H]1CCC2C3CCC4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@@]21C

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 8/20 0.69
▸ NR1H4 Q96RI1 4/20 0.69
▸ PDE3A Q14432 2/20 0.69
▸ SLC10A2 Q12908 2/20 0.69
▸ TBXA2R P21731 1/20 0.69
▸ MAPT P10636 3/20 0.64
▸ MAPK1 P28482 3/20 0.64
▸ USP2 O75604 2/20 0.64
▸ LMNA P02545 2/20 0.64
▸ MEN1 O00255 1/20 0.64
▸ KMT2A Q03164 1/20 0.64
▸ CA1 P00915 2/20 0.56
▸ CA2 P00918 2/20 0.56
▸ CASP7 P55210 3/20 0.55
▸ TP53 P04637 2/20 0.55
▸ HSD17B10 Q99714 2/20 0.55
▸ BLM P54132 2/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ MDM4 O15151 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23710340 1.00 GPBAR1 (0.69) GPBAR1NR1H4PDE3ASLC10A2TBXA2R
SCHEMBL23704685 1.00 GPBAR1 (0.69) GPBAR1NR1H4PDE3ASLC10A2TBXA2R
SCHEMBL26424226 1.00 GPBAR1 (0.69) GPBAR1NR1H4PDE3ASLC10A2TBXA2R
SCHEMBL26423994 0.95 MAPT (0.63) GPBAR1NR1H4PDE3ASLC10A2TBXA2R
SCHEMBL26423907 0.94 MAPT (0.62) GPBAR1NR1H4PDE3ASLC10A2TBXA2R
SCHEMBL23704728 0.91 MAPT (0.70) GPBAR1NR1H4PDE3ASLC10A2TBXA2R
SCHEMBL23710352 0.91 MAPT (0.70) GPBAR1NR1H4PDE3ASLC10A2TBXA2R
SCHEMBL23704741 0.91 MAPT (0.70) GPBAR1NR1H4PDE3ASLC10A2TBXA2R
SCHEMBL23710353 0.91 MAPT (0.70) GPBAR1NR1H4PDE3ASLC10A2TBXA2R
SCHEMBL23704727 0.91 MAPT (0.70) GPBAR1NR1H4PDE3ASLC10A2TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4097119-B1 BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES UNIV JOHNS HOPKINS (US) 2025-05-07 — — EP disclosed
EP-4097119-A1 BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES The Johns Hopkins University (US) 2022-12-07 — — EP disclosed
WO-2021155167-A1 BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES THE JOHNS HOPKINS UNIVERSITY (US) 2021-08-05 — — WO disclosed
Send feedback